1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Infant, Newborn, Diseases in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lopez, NC | 1 |
| Ebensperger, G | 1 |
| Herrera, EA | 1 |
| Reyes, RV | 1 |
| Calaf, G | 1 |
| Cabello, G | 1 |
| Moraga, FA | 1 |
| Beñaldo, FA | 1 |
| Diaz, M | 1 |
| Parer, JT | 1 |
| Llanos, AJ | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Altitude Sickness; Animals; Animals, Newborn; Humans; | 2016 |